Action(s) taken or orders passed

8th September 2026 The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Dalal Street Bandra-Kurla Complex, Mumbai 400 001 Bandra (E), Mumbai 400 051 Scrip Code: 500674 Symbol: SANOFI Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI (LODR) Regulations”) Dear Sir/Madam, In compliance with Regulation 30 of the SEBI (LODR) Regulations, we hereby inform that the Hon'ble Supreme Court of India (“Supreme Court”) vide its Order dated 7th September 2026 has dismissed the Company’s petition seeking quashing of the criminal proceedings. The Supreme Court ruling is on maintainability of criminal prosecution against the Company even where no individual employee is arraigned. The Supreme Court has not recorded any finding of guilt and has not adjudicated on the merits of the case. The matter relates to Appeal filed by the Company, for quashing the criminal complaint case filed by the Central Bureau of Investigation against the Company. The complaint relates to pharmaceutical supplies made to Bhabha Atomic Research Centre (“BARC”), Mysore between 2012 to 2015 and allegations of alleged conspiracy with a BARC Personnel to wrongfully influence procurement decisions. As on date the criminal Complaint case is pending for trial. The details of the above Order as required under Regulation 30 of the SEBI (LODR) Regulations are given below: 1 Name of the authority Hon'ble Supreme Court of India 2 Nature and details of the The Hon'ble Supreme Court of India action(s) taken, initiated or (“Supreme Court”) vide its Order dated order(s) passed 7th September 2026 has dismissed the Company’s petition seeking quashing of the criminal proceedings. The Supreme Court ruling is on maintainability of criminal prosecution against the Company even where no individual employee is arraigned. Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number: L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: igrc.sil@sanofi.com The Supreme Court has not recorded any finding of guilt and has not adjudicated on the merits of the case. 3 Date of receipt of direction or Order received by the Company on order, including any 7th September 2026 ad-interim or interim orders, or any other communication from the authority 4 Details of the The matter relates to Appeal filed by the violation(s)/contravention(s) Company, for quashing the criminal committed or alleged to be complaint case filed by the Central Bureau committed; of Investigation against the Company. The complaint relates to pharmaceutical supplies made to Bhabha Atomic Research Centre (“BARC”), Mysore between 2012 to 2015 and allegations of alleged conspiracy with a BARC Personnel to wrongfully influence procurement decisions. As on date the criminal Complaint case is pending for trial. 5 Impact on financial, operation The Company is assessing the judgment or other activities of the listed and formulating the next litigation entity, quantifiable in strategy. The judgment does not impose monetary terms to the extent any penalty, conviction, or operational possible. restriction on the Company at this stage. This is for your information and records. Thanking you, Yours faithfully For Sanofi India Limited Haresh Vala Company Secretary and Compliance Officer Membership No.: A18246 Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number: L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: igrc.sil@sanofi.com